OTTAWA, June 7, 2023 – Research Canada is proud to host its 18^th Annual General Meeting (AGM) where it will bring together Canada’s health research and health innovation communities to participate in a dynamic meeting with Parliamentarians and stakeholders from our coveted health research and innovation ecosystem.

From presentations on game-changing research on antimicrobial resistance (AMR) and pandemic preparedness to a networking luncheon with Parliamentarians, Research Canada will showcase outstanding Canadian health research and its related innovation while diving deep into the work with its Members and Board critical to our fall advocacy efforts. This invitation-only event, sponsored by GlaxoSmithKline Inc. (GSK), Innovative Medicines Canada, Queen’s University, University Health Network (UHN) and other generous Sponsors, promises to be one of the best opportunities to build momentum for a robust and collaborative fall advocacy campaign dedicated to immediately increasing investments in Canadian health research!

At this year’s AGM, Research Canada will also launch its new Strategic Plan, Vision 2025: Fulfilling the Promise of Collaborative Advocacy Leadership, which reconfirms and updates Research Canada’s three commitments to Amplify Its Influence, Broaden Public Reach and Diversify Its Alliance in a bold and dedicated effort to bring about meaningful policy change.

Date: Wednesday, June 7, 2023
Where: Fairmont Château Laurier, Ottawa, Ontario

About Research Canada

Research Canada is a national alliance dedicated to increasing investments in health research through collaborative advocacy and engaging government, academia, industry and non-profit sectors to build support for long-term health research funding. For more information, visit rc-rc.ca.

Since 2009, Parliamentary Health Research Caucus events on Parliament Hill have helped to educate politicians on the social and economic benefits of Canadian health research and innovation, as well as introduce them to the multi-sector partnerships among academic, private sector and health charity stakeholders essential to a robust health research enterprise and innovation system.